[Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection]
- PMID: 24769585
- DOI: 10.2222/jsv.63.93
[Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection]
Abstract
Poliovirus (PV) is a small non-enveloped virus belonging to the family Picornaviridae, and is the causative agent of poliomyelitis. With established vaccines, the global eradication program for poliomyelitis is ongoing by the World Health Organization since 1988. In the eradication program, antivirals are anticipated to have some roles in the endgame and post-eradication era of PV. During our search for potent anti-PV compounds, we identified candidate compounds that are associated with a common resistance mutation in viral protein 3A similar to enviroxime (designated as enviroxime-like compounds). Recently, PIK93, an inhibitor of host phosphatidylinositol 4-kinase III beta (PI4KB), was identified as a potent anti-enterovirus compound (Hsu et al., Cell 141:799-811). We found that PIK93 is an enviroxime-like compound, and showed that T-00127-HEV1, which is a novel enviroxime-like compound identified in high-throughput screening, is a specific PI4KB inhibitor. We also showed that PI4KB is an enterovirus-specific host factor required for its viral RNA replication. Analysis of anti-enterovirus compounds would unravel novel host factors that could serve as promising antiviral targets of prophylaxis and therapy of the infection.
Similar articles
-
Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.J Virol. 2011 Mar;85(5):2364-72. doi: 10.1128/JVI.02249-10. Epub 2010 Dec 22. J Virol. 2011. PMID: 21177810 Free PMC article.
-
Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III β Inhibitor.ACS Infect Dis. 2016 Feb 12;2(2):140-8. doi: 10.1021/acsinfecdis.5b00122. Epub 2015 Dec 16. ACS Infect Dis. 2016. PMID: 27624965
-
Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime.J Gen Virol. 2009 Aug;90(Pt 8):1869-1879. doi: 10.1099/vir.0.012096-0. Epub 2009 May 13. J Gen Virol. 2009. PMID: 19439558
-
Combating enterovirus replication: state-of-the-art on antiviral research.Biochem Pharmacol. 2012 Jan 15;83(2):185-92. doi: 10.1016/j.bcp.2011.08.016. Epub 2011 Aug 26. Biochem Pharmacol. 2012. PMID: 21889497 Review.
-
The life cycle of non-polio enteroviruses and how to target it.Nat Rev Microbiol. 2018 Jun;16(6):368-381. doi: 10.1038/s41579-018-0005-4. Nat Rev Microbiol. 2018. PMID: 29626210 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
